- Release Date: 19/10/21 09:32
- Summary: Secures Funds for 3rd Trial of NTCELL in Parkinson Disease
- Price Sensitive: Yes
- Download Document 542.63KB
Ann: Secures Funds for 3rd Trial of NTCELL in Parkinson Disease
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.001(10.0%) |
Mkt cap ! $18.55M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 1.0¢ | $12.06K | 1.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3938723 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 1038024 | 6 |
View Market Depth
| Last trade - 14.43pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
1.1¢ |
Change
0.001 ( 5.00 %) |
||||
| Open | High | Low | Volume | ||
| 1.0¢ | 1.1¢ | 1.0¢ | 507212 | ||
| Last updated 15.42pm 29/04/2024 ? | |||||
| 1AI (ASX) Chart |